Equifax (NYSE:EFX) Stock Price Target Lowered at Mizuho
by Danessa Lincoln · The Markets DailyEquifax (NYSE:EFX – Get Free Report) had its target price dropped by investment analysts at Mizuho from $210.00 to $185.00 in a report released on Monday, Benzinga reports. The firm currently has an “outperform” rating on the credit services provider’s stock. Mizuho’s price target would indicate a potential upside of 14.76% from the company’s current price.
Several other equities research analysts also recently commented on EFX. Weiss Ratings upgraded Equifax from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, August 13th. Oppenheimer cut shares of Equifax from an “outperform” rating to a “market perform” rating in a research note on Friday. Wells Fargo & Company dropped their price target on shares of Equifax from $212.00 to $200.00 and set an “overweight” rating on the stock in a report on Tuesday, September 22nd. Rothschild & Co Redburn raised shares of Equifax from a “neutral” rating to a “buy” rating and raised their price target for the company from $214.00 to $235.00 in a report on Friday, August 21st. Finally, JPMorgan Chase & Co. reduced their price target on shares of Equifax from $230.00 to $210.00 in a research note on Wednesday, July 22nd. Fourteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $201.05.
Read Our Latest Stock Analysis on Equifax
Equifax Stock Performance
Shares of EFX opened at $161.21 on Monday. The company has a market cap of $18.94 billion, a price-to-earnings ratio of 28.33, a P/E/G ratio of 1.69 and a beta of 1.35. The business’s fifty day simple moving average is $167.52 and its two-hundred day simple moving average is $170.10. Equifax has a 12 month low of $137.01 and a 12 month high of $238.94. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.92.
Equifax (NYSE:EFX – Get Free Report) last posted its quarterly earnings results on Tuesday, July 21st. The credit services provider reported $2.25 earnings per share for the quarter, topping the consensus estimate of $2.20 by $0.05. The firm had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.70 billion. Equifax had a return on equity of 21.61% and a net margin of 10.73%. The company’s revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.00 earnings per share. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. Research analysts anticipate that Equifax will post 8.53 earnings per share for the current fiscal year.
Insider Transactions at Equifax
In related news, CEO Mark Begor sold 37,791 shares of the business’s stock in a transaction that occurred on Friday, July 24th. The stock was sold at an average price of $172.16, for a total transaction of $6,506,098.56. Following the completion of the transaction, the chief executive officer directly owned 271,890 shares in the company, valued at approximately $46,808,582.40. The trade was a 12.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP John W. Gamble, Jr. sold 4,500 shares of the company’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $187.96, for a total transaction of $845,820.00. Following the completion of the transaction, the executive vice president owned 69,055 shares of the company’s stock, valued at approximately $12,979,577.80. The trade was a 6.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by insiders.
Institutional Investors Weigh In On Equifax
A number of hedge funds have recently made changes to their positions in the company. Raiffeisen Bank International AG boosted its position in shares of Equifax by 1.5% during the 2nd quarter. Raiffeisen Bank International AG now owns 3,590 shares of the credit services provider’s stock valued at $569,000 after acquiring an additional 53 shares during the last quarter. V Square Quantitative Management LLC increased its position in Equifax by 3.8% in the first quarter. V Square Quantitative Management LLC now owns 1,730 shares of the credit services provider’s stock worth $312,000 after purchasing an additional 64 shares during the last quarter. Droms Strauss Advisors Inc. MO ADV increased its position in Equifax by 1.9% in the first quarter. Droms Strauss Advisors Inc. MO ADV now owns 5,435 shares of the credit services provider’s stock worth $979,000 after purchasing an additional 100 shares during the last quarter. Glenmede Trust Co. NA raised its stake in Equifax by 0.8% during the first quarter. Glenmede Trust Co. NA now owns 13,647 shares of the credit services provider’s stock valued at $2,457,000 after purchasing an additional 102 shares in the last quarter. Finally, Reflection Asset Management purchased a new stake in Equifax during the fourth quarter valued at $26,000. 96.20% of the stock is currently owned by hedge funds and other institutional investors.
About Equifax
Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that provides information and services to help businesses, governments and consumers make informed financial and workforce decisions. The company is best known for its credit reporting activities, but its offerings also include identity verification, fraud prevention, income and employment verification, marketing services and risk management solutions.
Equifax provides consumer and commercial credit information, credit reports and related analytics to lenders and other businesses.
Further Reading
- Five stocks we like better than Equifax
- 2026’s ETF Boom Is Approaching 2,000 Launches: Watch These 3
- Microsoft’s New AI Chip Could Change the Economics of AI
- What a Mixed Midterm Result Could Mean for These 2 Health Care ETFs
- These 3 Green Stocks Have a Growth Story That Goes Far Beyond Washington